Clinical Research Directory
Browse clinical research sites, groups, and studies.
Research on Potential Biomarkers of Prediabetes and Diabetes Based on MALDI-TOF MS Platform.
Sponsor: Zhujiang Hospital
Summary
Through the MALDI-TOF MS platform, explore the proteomics and peptidomics differences of fasting serum/plasma and urine between non pregnant people with normal glucose tolerance test and prediabetes /diabetes patients, pregnant people with normal glucose tolerance test and pregnant diabetes patients respectively; To explore the role of its proteomics and peptidomics differences in the diagnosis of prediabetes and diabetes, and to establish a new method of differential diagnosis by using the omics data and key characteristic peaks to find potential new diagnostic markers.
Key Details
Gender
All
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
2860
Start Date
2022-05-20
Completion Date
2026-12-31
Last Updated
2023-10-24
Healthy Volunteers
Yes
Interventions
Oral Glucose Tolerance Test
Grouping based on detected oral glucose tolerance test results without any other intervention.
Locations (1)
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, China